3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
4
Other solid neoplasm
1
Head & Neck
1
Dermatologic
1
Conditions
Mesothelioma
3
Solid Tumor, Adult
2
Solid Tumor
2
Retinoblastoma
2
Thyroid Neoplasms
1
Thymus Neoplasms
1
Small Cell Lung Carcinoma
1
Pneumothorax
1
Pleural Neoplasms
1
Pediatric Solid Tumor, Unspecified, Protocol Specific
1
Parathyroid Neoplasms
1
Neoplasms
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Hemostatic Disorders
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Anatomic Stage III Breast Cancer AJCC v8
1
Advanced Solid Tumor
1
Adenocarcinoma
1
Interventions
pembrolizumab
6
Nivolumab
3
tislelizumab
2
budigalimab
2
Ipilimumab
2
Depsipeptides
2
Decitabine
2
venetoclax
1
talazoparib
1
spartalizumab
1
sargramostim
1
rovalpituzumab tesirine
1
regorafenib
1
poly ICLC
1
iodixanol
1
epacadostat
1
entinostat
1
durvalumab
1
cemiplimab
1
avelumab
1
atezolizumab
1
alvocidib
1
Tomography, Optical Coherence
1
Tissue Banks
1
Tablets
1
Radiosurgery
1
Radiofrequency Ablation
1
Paclitaxel
1
Iohexol
1
Interferon-gamma
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Blood Specimen Collection
×
Other solid neoplasm
×
Clear all
NCT07550049
2026-04-24
COMETH
University of Kansas Medical Center
Not yet recruiting
110 enrolled